CB-154

Known as: CB 154, CB154 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
The proliferative activity of vascular cells and the number of macrophages were studied in corpora lutea of cycling and pregnant… (More)
Is this relevant?
1989
1989
Hypoprolactinaemia was induced by bromocriptine (CB154; 100 mg/day) which decreased circulating prolactin by 40% (P less than 0… (More)
Is this relevant?
1986
1986
Treatment of immature female rats with 100 micrograms 2-bromo-alpha-ergocryptine mesylate (CB-154) per ml drinking water… (More)
Is this relevant?
1982
1982
The effects of bromocryptine (CB-154) on prolactin (PRL) and luteinizing hormone (LH) secretion were studied in lactating sows… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1982
1982
Foeto-placental function and hormone levels in the maternal, foetal and amniotic compartments have been investigated in an… (More)
Is this relevant?
1981
1981
The influence of periparturient secretion of PRL on cytological differentiation of mammary epithelial cells was studied in 17… (More)
Is this relevant?
1981
1981
A 23-year-old woman was receiving bromocriptine (CB-154, 7.5-10 mg/day, for a hyperprolactinemic galactorrhea-amenorrhea syndrome… (More)
Is this relevant?
1978
1978
In 12 acromegalics a single oral dose of 0.2 mg lisuride, an ergoline derivative, significantly reduced plasma PRL but not GH… (More)
Is this relevant?
1978
1978
Bromocriptine produces long-lasting hypomotility and decreases brain dihydroxyphenylacetic acid (DOPAC) in mice. These effects… (More)
Is this relevant?
1976
1976
Plasma testosterone, androstenedione, oestradiol-17beta, follicle stimulating hormone (FSH) and luteinizing hormone (LH) were not… (More)
Is this relevant?